Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic Anemia
Condition(s):Refractory Aplastic AnemiaLast Updated:August 30, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Refractory Aplastic AnemiaLast Updated:August 30, 2022Terminated
Condition(s):Aplastic AnemiaLast Updated:March 1, 2011Unknown status
Condition(s):Refractory Aplastic AnemiaLast Updated:August 26, 2022Recruiting
Condition(s):Refractory Idiopathic Aplastic Anemia; Haploidentical Allogeneic Hematopoietic Stem Cell TransplantationLast Updated:November 24, 2023Recruiting
Condition(s):Aplastic AnemiaLast Updated:January 26, 2018Terminated
Condition(s):Anemia, Aplastic; Anemia, Hypoplastic; ThrombocytopeniaLast Updated:October 20, 2020Completed
Condition(s):Aplastic AnemiaLast Updated:October 5, 2023Recruiting
Condition(s):Anemia, AplasticLast Updated:October 7, 2008Unknown status
Condition(s):Severe Aplastic AnemiaLast Updated:October 13, 2016Terminated
Condition(s):Aplastic Anemia; Neutropenia; Pancytopenia; Severe Aplastic AnemiaLast Updated:July 2, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.